PCSK9 and irritable bowel syndrome: Additionally, this altered microbiome can affect TMAO through an increase in Proteobacteria and other TMA producers, and PCSK9 through conditions such as small intestinal bacterial overgrowth (SIBO) or irritable bowel syndrome (IBS), which are both correlated with increased PCSK9 production.